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Abstract
Previous studies have demonstrated that long chain fatty acids influence fibroblast function at sub-lethal
concentrations. This study is the first to assess the effects of oleic, linoleic or palmitic acids on protein expression of
fibroblasts, as determined by standard proteomic techniques. The fatty acids were not cytotoxic at the
concentration used in this work as assessed by membrane integrity, DNA fragmentation and the MTT assay but
significantly increased cell proliferation. Subsequently, a proteomic analysis was performed using two dimensional
difference gel electrophoresis (2D-DIGE) and MS based identification. Cells treated with 50 μM oleic, linoleic or
palmitic acid for 24 h were associated with 24, 22, 16 spots differentially expressed, respectively. Among the
identified proteins, a-enolase and far upstream element binding protein 1 (FBP-1) are of importance due to their
function in fibroblast-associated diseases. However, modulation of a-enolase and FBP-1 expression by fatty acids
was not validated by the Western blot technique.
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Introduction
Found in the majority of tissues of the body, fibroblasts are
responsible for the synthesis and secretion of most extra-
cellular matrix (ECM) components, such as proteoglycans,
collagens, laminin and fibronectin, which bind to proteins
expressed on cell surfaces thus modulating physiologic
responses. Fibroblasts can also secrete proteinases, includ-
ing matrix metalloproteinases and plasminogen, hence
playing an important role in ECM degradation and tissue
remodeling [1-3].
The dysregulation of fibroblast biology is associated with
several diseases and pathological states, including deficient
wound healing [4-6], pulmonary diseases [7,8], cardiovas-
cular diseases [9,10] and cancer [11]. Therefore, the dis-
covery of new therapies modulating fibroblast biology
could be a powerful target to develop treatment against
such diseases. Oleic (18:1n-9), linoleic (18:2n-6) and pal-
mitic (16:0) acids are the most abundant fatty acids in the
western diets [12]. The latter is a saturated fatty acid
found in palm oil, butter, milk, cheese and meats, whereas
oleic acid is a monounsaturated fatty acid found in olive
oil, meat, eggs and milk and linoleic acid is a polyunsatu-
rated fatty acid found in soybean, sunflower, safflower and
corn oils. The effects of prostaglandin derived from n-3
and n-6 fatty acids on specific protein expression (e.g.
COX-2 and IL-6) in NIH 3T3 fibroblasts [13] and some
aspects of the impact of fatty acids on process involving
fibroblast function [14-16] have been reported. However,
no systematic study has assessed the pleiotropic effects of
fatty acids on fibroblast protein expression. Therefore, the
aim of this study was to assess the effects of oleic (OLA),
linoleic (LNA) or palmitic acids (PAM) on protein expres-
sion of NIH 3T3 fibroblasts, as determined by 2D-DIGE, i.
e., separation of proteins by isoelectric focusing in the first
dimension followed by SDS-PAGE in the second. This
approach has been successful in elucidating the actions of
palmitic acid on protein expression in a clonal pancreatic
beta cell line, INS-1E [17].
Results
Effect of fatty acids on fibroblast membrane and DNA
integrity
Fibroblast cells were incubated in the presence 50 μM
oleic, linoleic or palmitic acids for 24 h. Membrane
integrity and DNA fragmentation assays indicated that
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tration (Figure 1).
Effect of fatty acids on relative cell number as assessed
by MTT assay
The treatment of fibroblasts with 50 μM oleic, linoleic
or palmitic acids increased relative cell number by 1.32-
fold (p < 0.01), 1.32-fold (p < 0.05) or 1.29-fold (p <
0.05), respectively, as assessed by MTT absorbance
(Figure 2). However, the treatment with 300 μM palmi-
tic acid (known to be cytotoxic) decreased relative cell
number by 50% (Figure 2).
2D-DIGE and MS based protein identification
Using 2D-DIGE and Progenesis Samespots v 3.2 analyses
software, a protein profile from control or fatty acid
(oleic, linoleic or palmitic acids) treated fibroblasts was
assessed. Comparing protein expression using Student’s t
test, cells treated with oleic, linoleic and palmitic acid
showed 24, 22, 16 spots significantly differentially
expressed (p < 0.05), respectively, when compared to
control, whereas 9, 8, 6 of them were associated with a
power > 0.8, respectively. According to spot intensity and
matching from DIGE to preparative gels, 11 spots were
chosen to be identified using MS (Figure 3). The majority
of the spots identified contained one or two proteins
when data was searched against the Swiss Prot mouse
databases using Turbosequest. However, the identified
proteins were not matched against their position in the
gel according to their molecular weight and isoeletric
point (Table 1).
Protein analysis by Western blot
Based on results obtained using 2D-DIGE and MS we
selected a-enolase and FBP-1 due to their functional
importance in fibroblast-associated diseases. Therefore,
western blotting was performed in order to validate our
previously described results (Table 1). In addition, c-
myc expression was assessed since FBP-1 is a known
modulator (see discussion). The expression of these
three proteins was not altered by treatment with fatty
acids (Figure 4).
Discussion
In order to fully comprehend a biological network, the
expression information from mRNA and concentration
change in protein is required. The importance of pro-
teomic analysis is emphasised when differences between
the relative expression levels of mRNA and their corre-
sponding proteins are demonstrated [18]. Several studies
have analysed the effects of fatty acids on the gene
expression profile of different cell and tissue types
[19-24] but relatively few have studied such effects
based on proteomic approaches. Our study is the first to
investigate the effects of oleic (monounsaturated), lino-
leic (polyunsaturated) or palmitic (saturated) acids on
protein expression of murine fibroblasts and related this
to a functional outcome, cell proliferation.
To test the cytotoxicity or proliferative activity of the
fatty acids, NIH 3T3 cells were treated with 50 μM fatty
acids over 24 hours and both cell viability and relative
cell number were assessed using flow cytometry and
MTT assay, respectively. This concentration is able to
cause biological effects on other cell types [25-27] and is
in the physiological range for plasma free fatty acids
[28,29]. There was no difference between control and
fatty acid treated cells based on membrane integrity and
DNA fragmentation measurements, although results
from the MTT assay indicated an increase in relative
cell number (proliferation) in cells treated with 50 μM
oleic, linoleic or palmitic acids. Oleic and linoleic acids
increase skeletal muscle cell proliferation, whereas
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Figure 1 Analysis of membrane integrity (a) and DNA fragmentation (b): NIH 3T3 fibroblasts (10
5 cells) were treated with vehicle
control (C), 50 μM OLA, LNA or PAM for 24 h. Results are presented as mean ± standard error of the mean (SEM) of at least 4 (membrane
integrity) or 8 (intact DNA) independent samples.
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Page 2 of 8palmitic acid does not affect it [30]. Moreover, oleic and
linoleic acids promote proliferation of epithelial cells
[31].
Subsequently, a proteomic analysis was performed
using 2D-DIGE. Cells treated with oleic, linoleic or pal-
mitic acid for 24 h were associated with 24, 22, 16 spots
differentially expressed, respectively, and 11 of them
were identified by mass spectrometry using LC/MS/MS.
Among the identified proteins, a-enolase and FBP-1 are
of importance due to their function in fibroblast-asso-
ciated diseases. In addition to its role in glycolysis, a-
enolase is a cell-surface plasminogen-binding site form-
ing plasmin, which is responsible for degradating extra-
cellular matrix compounds, such as collagen, fibrin,
fibronectin and laminin [32]. Therefore, signaling
initiated by plasminogen binding to the cell surface has
important implications for physiological and pathologi-
cal events, such as wound healing, tissue remodeling
and tumor cell diffusion [33]. FBP modulates c-myc
expression through binding to FUSE, that is upstream to
P2 promoter [34-37]. The transcription factor c-myc
plays a role in the regulation of approximately 10% of
cell genes and is involved in proliferation and metabo-
lism and hence it is considered a proto-oncogene
[38,39].
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Figure 2 Analysis of relative cell number using the MTT assay:
NIH 3T3 fibroblasts (6 × 10
3 cells) were treated with vehicle
control (C), 300 μM palmitic acid (positive control - PC), 50 μM
OLA, LNA or PAM for 24 h. Results are presented as mean ± (SEM) of
at least 7 independent samples. *p < 0.05, **p < 0.01 and ***p < 0.001
comparing to control (ANOVA and Dunnett post hoc test).
Figure 3 Analysis of protein expression using 2D-DIGE: The figure is a representative image of the gel with the excised and identified
spots.
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Western blot results which describe the fatty acid depen-
dent changes in expression level of two specific proteins.
However, differences in protein expression using the lat-
ter techniques have also been reported by other groups
[17,40]. The discrepancy may be explained by the fact
that the Western blot technique cannot separate different
forms of proteins with specific post-translational modifi-
cations (for example, glycosylation), whereas 2D gels are
able to detect differences, therefore 2D gel analysis is
more precise. However, it should be noted that the
analysis from mass spectrometry in the present study
identified two proteins in some spots, thus the use of
Western blot was important for confirmation purposes.
In conclusion, although previous studies have reported
potent effects of fatty acids on fibroblast, our results sug-
gest that changes in protein expression using 50 μM oleic,
linoleic or palmitic acids for 24 h were relatively minor.
However, it should be noted that relatively small changes
in protein expression can lead to a significant change in
cell proliferation.
Materials and methods
Chemicals and reagents
Oleic, linoleic and palmitic acids, Cell Growth Determina-
t i o nK i tM T TB a s e da n dP r o p i d i u mI o d i d ew e r ep u r -
chased from Sigma-Aldrich( S t .L o u i s ,M O ,U S A ) .
Dulbecco’s Modified Eagle Medium (DMEM), Penicillin
Streptomycin (Pen Strep) and Fetal Bovine Serum (FBS)
were purchased from Invitrogen (Carlsbad, CA, USA).
Antibodies against a-enolase and c-myc were purchased
from Cell Signaling Technology (Beverly, MA, USA) and
antibody against FBP-1 was from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA).
Culture conditions
NIH 3T3 fibroblasts were cultured in DMEM medium
supplemented with 10% FBS, 100 U/mL Penicilin and
Table 1 Proteins are described followed by accession number and the number of peptides identified using mass
spectrometry of excised spots
Spot Identified proteins, accession number and number of peptides Fatty acid (FA) Control/FA ratio Statistics
1 a-enolase (P17182 - 11 peptides);
Mitochondrial processing peptidase subunit beta
(Q9CXT8 - 3 peptides)
OLA
LNA
1.1
1.1
p < 0.05; power > 0.8
p < 0.05; power > 0.8
2 26S protease regulatory subunit 8
(P62196 - 12 peptides)
LNA
OLA
PAM
1.1
1.1
1.1
p < 0.05; power > 0.8
p < 0.05
p < 0.05
3 Histone H$ (P62806 - 2 peptides);
Histone H1.2 (P15864 - 2 peptides)
LNA 0.9 p < 0.05; power > 0.8
4 ATP synthase subunit beta (P56480 - 4 peptides);
Eukaryotic translational initiation factor 5A (P63242 - 2 peptides)
OLA 1.2 p < 0.05; power > 0.8
5 Nothing identified OLA
PAM
1.1
1.1
p < 0.05; power > 0.8
p < 0.05
6 Heterogeneous nuclear ribonucleoprotein L
(Q8R081 - 9 peptides);
Lamin A/C (P48678 - 7 peptides)
OLA 1.1 p < 0.05; power > 0.8
7 FK506-binding protein 4 (P30416 - 6 peptides);
Transcription factor BTF3 (Q64152 - 3 peptides)
PAM
OLA
1.1
1.1
p < 0.05; power > 0.8
p < 0.05
8 Heterogeneous nuclear ribonucleoprotein (Q8R081 - 2 peptides) PAM
OLA
1.1
1.1
p < 0.05; power > 0.8
p < 0.05
9 a-enolase (P17182 - 10 peptides) PAM 1.1 p < 0.05; power > 0.8
10 a-enolase (P17182 - 10 peptides);
40 kDa Peptidyl prolyl cis-trans isomerase (Q9CR16 - 4 peptides)
PAM
OLA
1.1
1.05
p < 0.05; power > 0.8
p < 0.05
11 a-enolase (P17182 - 5 peptides);
Far upstream element-binding protein 1 (Q91WJ8 - 4 peptides)
PAM 1.1 p < 0.05; power > 0.8
Where appropriate, fatty-acid treatment that significantly changed protein expression is indicated (p < 0.05). Abbreviations: LNA (linoleic acid), OLA (oleic acid)
and PAM (palmitic acid).
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Figure 4 Analysis of protein expression using the Western Blot
technique: Effects of oleic, linoleic or palmitic acid on a-
enolase, FBP-1 and c-myc expression. The analysis was performed
by Western blot using 40 μg protein from NIH 3T3 fibroblasts
treated with vehicle control (C), 50 μM OLA, LNA or PAM for 24 h.
Representative Western blot of six independent experiments. b-
Actin was used as an expression control.
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humidified incubator at 37°C in an atmosphere of 5%
CO2. After 3 h of incubation (for all the experiments
except Western blot), the samples were washed with
PBS (KCl 2.7 mM, NaCl 136.8 mM, Na2HPO4 anhy-
drous 6.4 mM, KH2PO4 0.9 mM - pH 7.4) and treated
with 50 μM oleic, linoleic or palmitic acids in the above
medium for 24 h. Ethanol was used as control treatment
and its final concentration did not exceed 0.16%.
Fatty-acid cytotoxicity as determined by membrane
integrity and DNA fragmentation
In order to evaluate fatty-acid cytotoxicity, membrane
integrity and DNA fragmentation were measured using
flow cytometry. Fibroblasts (10
5 cells) were incubated in 6-
well plates in a final volume of 1 mL. After 24 h of treat-
ment with the fatty acids, the cells were harvested using
trypsin, followed by centrifugation at 500 g. For membrane
integrity assay, cells were then re-suspended in 200 μL
PBS and 20 μL propidium iodide solution (20 μg/mL in
PBS) was added to each sample. For DNA fragmentation,
cells were resuspended in 200 μL lysis buffer (0.1% sodium
citrate and 0.1% Triton X-100) with 20 μg/mL propidium
iodide and were then incubated in dark for 30 minutes.
Subsequently, cells were analysed (8000 cells/sample) in a
flow cytometer (FACSCalibur, Becton Dickinson, San
Juan, CA, USA) using Cell Quest software. Propidium
iodide is a water-soluble fluorescent compound that can-
not pass through intact plasma membrane. Therefore,
when plasma membrane is disrupted, propidium iodide
enters the cells and intercalates between DNA bases,
which is identified by high fluorescence emission. Like-
wise, in the DNA fragmentation assay, propidium iodide
intercalates in the exposed DNA after cell lysis and the
presence of low-fluorescent fragments is indicative of
DNA fragmentation. Fluorescence was measured using
FL2 channel (orange-red fluorescence-585/42nm).
Relative cell number as determined by the MTT assay
MTT assay (Sigma Aldrich, St. Louis, MO, USA) is a col-
orimetric assay that indirectly measures cellular dehydro-
genase enzyme activity, which is mainly associated with
functional mitochondria. The MTT salt in the oxidized
form is yellow and water-soluble and can be reduced, for
example, by mitochondrial succinate dehydrogenase pre-
sent in viable cells to formazan crystals. An increase in the
number of viable cells results in an increase in the overall
activity of mitochondrial dehydrogenases in the sample,
for example, as assessed by the WST-1 assay [41]. Fibro-
blasts (6 × 10
3 cells) were incubated in 96-well plates in a
final volume of 100 μL. For positive control (higher death
rate), 300 μM palmitic acid was used. After 24 h of treat-
ment with the fatty acids, the supernatants were discarded
and 100 μL 0.1 N HCl in anhydrous isopropanol was
added in order to dissolve the formazan crystals. After dis-
solution, sample absorbance was measured in spectrophot-
ometer (570 nm and 690 nm) and plotted as the difference
between the results found in both wavelengths, as speci-
fied by the supplier.
Sample preparation for 2D-DIGE
Cells were incubated in 100% confluence in a final volume
of 1 mL. After 24 h of treatment with the fatty acids, sam-
ples were harvested. For harvesting the cells, the superna-
tant was removed and the cells were carefully washed four
times in an isotonic sucrose solution (0.35 M). A lysis buf-
fer (9.5 M urea; 2% CHAPS) was added and three wells
pooled for each sample. Subsequently, the samples were
sonicated and centrifuged at 500 g in a microcentrifuge.
The supernatant was collected and the protein concentra-
tions were determined using a modified protein assay [42].
The samples were then stored at -80°C.
CyDye labeling
In order to run 2D-DIGE, the samples were previous
labeled with fluorescent dyes. A CyDye (Amersham, GE
Healthcare) stock solution (1 mM) was made adding anhy-
drous DMF and stored at -20°C. The Cy3 (Amersham
CyDye DIGE Fluor Cy3 minimal dye, GE Healthcare, 25-
8008-61) and Cy5 (Amersham CyDye DIGE Fluor Cy5
minimal dye, GE Healthcare, 25-8008-62) solutions were
prepared (400 μM) using the CyDye stock solution and
anhydrous dimethylformamide (DMF).
After thawing, each sample was adjusted to a final con-
centration of 5 μg/μL and pH between 8 and 9. Forty
microgram of protein from fifteen samples (three from
each group sample: control, oleic, linoleic and palmitic)
were independently labeled with 0.8 μL of Cy5 solution. A
pool standard was then prepared by mixing fifty-five
microgram of all fifteen samples and the resulting mixture
was labeled with 16.5 μL of Cy3. All the samples, including
the pool standard, were kept in the dark for 30 min and
the reaction was then stopped by the addition of lysine (10
mM) for 10 min on ice. DIGE dilution buffer (9.5 M Urea;
2% CHAPS; 2% DTT; 1.6% Pharmalyte) was added to each
sample so that the final volume was doubled.
Fifteen mixtures were prepared, each made of one
sample labeled with Cy5 and the pool standard labeled
w i t hC y 3 .T h e s em i x t u r e sw e r es t o r e da t- 8 0 ° Cf o rs u b -
sequent running independent 2D gels.
2D-DIGE
Rehydration buffer (8 M Urea; 0.5% CHAPS; 0.2% Phar-
malyte; 0.2% DTT) was added to each sample so that
the final volume was 450 μL. Strips (24 cm, pH 3-10,
non-linear) were then rehydrated overnight with such
solutions and covered with IPG Cover Fluid (Amersham,
17-1335-01) to avoid dehydration. After rehydration, the
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ered with dry strip cover fluid. The isoeletric focusing
was carried out on the IPGphor III IEF system (GE
Healthcare) according to the following parameters: Step,
3500 V, 7500 vHrs; Gradient, 8000 V, 10 minutes; Step,
8000 V, 1 h; Step, 100 V, 12 h. Subsequently, the strips
were equilibrated for 15 minutes in equilibration buffer
(6 M Urea, 50 mM TrisCl pH 8.8, 30% (v/v) Glycerol,
2% (w/v) SDS) containing 1% (w/v) DTT and 15 min in
equilibration buffer containing 2.5% (w/v) iodoaceta-
mine. The strips were then briefly washed in SDS elec-
trophoresis buffer (25 mM Tris; 192 mM Glycine; 0.1%
(w/v) SDS) and placed on the top of 1 mm gels pre-
viously prepared (National Diagnostics ProtoGel kit,
30% acrylamide). 1% w/v agarose solution was poured
on the top of each gel in order to seal and fix the strip
on the gel. Following, second dimension separation was
performed in a Protean Plus Dodeca cell (Bio-Rad, UK)
with SDS electrophoresis buffer at 15°C. The gels were
run at 0.2 W/gel for 1 h, followed by 1 W/gel overnight.
Gel images were scanned with a Typhoon 9410 Variable
Mode Imager (GE Healthcare) and analysed using Pro-
genesis Samespots v 3.2. A significant difference
between control and fatty-acid treated samples was set
at p < 0.05 and power > 0.8 when analysed by Student’s
t-test.
Sample preparation for mass spectrometry analysis
Eleven protein spots, which were significantly differentially
expressed between control and treated cells, were excised
from preparative gels, which were silver-stained using a
commercial kit (Silver Stain PlusOne; Amersham Pharma-
cia Biotech, Amersham, UK). The silver-stained spots of
interest were manually excised, placed into 1.5 mL tubes
a n dw a s h e di nd d H 20 at 4°C overnight. The gel plugs were
then destained and dehydrated, followed by their protein
digestion and peptide extraction. For destaining, an equal
volume of 30 mM potassium ferricyanide and 100 mM
sodium thiosulphate was added to the gel plugs and incu-
bated at room temperature with occasional shaking until
the brown colour had disappeared. The supernatants were
discarded and the plugs were washed three times with
ddH20. They were then incubated in 200 mM NH4HCO3
for 20 min at room temperature on a thermomixer. For
dehydrating, the supernatants were removed and replaced
with 200 mM NH4HCO3:ACN::2:3 solution. The gel plugs
were incubated at 37°C on a thermomixer for 10 min with
gentle shaking. After briefly spinning, the supernatants
were discarded and the plugs were incubated with 70 μlo f
50 mM NH4HCO3 at 37°C on a thermomixer for 10 min
with gentle shaking. After briefly spinning, the superna-
tants were discarded and gel plugs were dried at 37°C on a
Speedivac until they were white in colour. For digesting
the proteins, the gel plugs were rehydrated in trypsin
solution (Promega, UK, 20 ng/μli n2 5m MN H 4HCO3,
pH 8.4) on ice for 45 min. The supernatants were removed
and the gel plugs covered with 25 mM NH4HCO3,p H8 . 4 ,
and incubated at 37°C overnight on a thermomixer. For
extracting the peptides, the supernatants were saved in
separate tubes and the tryptic peptides were extracted
three times with 50 μl of 70% acetonitrile, 5% formic acid.
Each extraction was sonicated for 5 min and the superna-
t a n t sf r o mt h es a m es a m p l ew e r ec o m b i n e d .T h e s ew e r e
then dried in a Speedivac and stored at -20°C for subse-
quent protein identification using mass spectrometry.
Mass spectrometry (MS) analysis
The proteins were identified by Thermo Finnegan LTQ
mass spectrometer, using LC/MS/MS. All of the data
was searched against the Swiss Prot mouse databases
using Turbosequest. Peptides with a probabililty of
>0.001 were discounted.
Western blot
Fibroblasts (10
6 cells) were incubated in 75 mm
2 flasks in
a final volume of 10 mL. After 24 h, supernatants were
discarded and the cells were incubated with 50 μMo f
oleic, linoleic or palmitic acids in DMEM (10% FBS) in a
final volume of 12 mL for 24 h. Subsequently, superna-
tants were discarded and flasks were washed two times
with ice-cold PBS. For protein extraction, 250 μL extrac-
tion buffer (10 mM EDTA, 100 mM TRIS, 10 mM
sodium pyrophosphate, 100 mM sodium fluoride, 10 mM
sodium vanadate, 2 mM PSMF, 3% aprotinin, 1% Triton
X-100) was added, the cells were scraped and then har-
vested. After 10 min of shaking in 4°C, samples were cen-
trifuged (11000 rpm, 15 min, 4°C) and the proteins in the
supernatants were quantified by the Bradford method.
Subsequently, Laemmli sample buffer with 200 mM
dithiothreitol (DTT) was added to the samples. They
were then boiled for 5 min and frozen at -80°C.
For immunoblotting, the samples were boiled for 5 min
and 40 μg of total protein was separated by SDS-PAGE,
transferred to nitrocellulose membranes, and blotted
with anti-enolase-1 (Cell Signaling Technology, #3810),
anti-FBP-1 (Santa Cruz Biotechnology Inc, SC-11101),
anti-c-Myc (Cell Signaling Technology, #9402) and anti-
b-Actin (Cell Signaling Technology, #4967). Subse-
quently, the blots were incubated with HRP-conjugate
antibodies for 2 h and bands were detected by chemilu-
minescence using Amersham Biosciences (RPN 2209),
with following exposure of the membranes to radio-
graphic films. b-Actin was used as an expression control.
Statistical analysis
For all the experiments except 2D-DIGE, the compari-
son between control and samples treated with oleic,
linoleic or palmitic acids were performed using ANOVA
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son between control and samples treated with oleic,
linoleic or palmitic acids were performed using Stu-
dent’s t test.
Abbreviations
2D-DIGE: two dimensional difference gel electrophoresis; ECM: extracellular
matrix; FBP-1: far upstream element binding protein 1; FUSE: far upstream
element; LNA: linoleic acid; OLA: oleic acid; PAM: palmitic acid.
Acknowledgements
We thank UCD Conway Institute for providing access to proteomic facilities
during the course of this work. This study was supported by Fundação de
Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de
Desenvolvimento Científico e Tecnológico (CNPq) and Coordenação de
Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Author details
1Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
2Institute of Physical Activity and Sport Sciences, University Cruzeiro do Sul,
Sao Paulo, Brazil.
3School of Biomolecular and Biomedical Science, University
College Dublin, Dublin, Ireland.
4School of Biomedical Sciences, Curtin
University, Perth, Western Australia 6845, Australia.
Authors’ contributions
JM conceived the study, participated in its design, acquisition of data,
statistical analysis and drafted the manuscript; EH conceived the study and
participated in its design; TR participated in the Western Blotting; HGR
participated in the MTT assay; WMTK participated in the Western Blotting; CS
participated in the 2D-DIGE and carried out mass spectrometry analysis; PN
participated in the design of the study and helped to draft the manuscript;
RC conceived the study, participated in its design and coordination and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 18 October 2011 Accepted: 24 November 2011
Published: 24 November 2011
References
1. McAnulty RJ: Fibroblasts and myofibroblasts: their source, function and
role in disease. Int J Biochem Cell Biol 2007, 39:666-671.
2. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr
Opin Cell Biol 1995, 7:728-735.
3. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ: Mechanisms of tissue
repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997,
29:5-17.
4. Wang HJ, Pieper J, Schotel R, van Blitterswijk CA, Lamme EN: Stimulation of
skin repair is dependent on fibroblast source and presence of
extracellular matrix. Tissue Eng 2004, 10:1054-1064.
5. van der Veer WM, Bloemen MC, Ulrich MM, Molema G, van Zuijlen PP,
Middelkoop E, Niessen FB: Potential cellular and molecular causes of
hypertrophic scar formation. Burns 2009, 35:15-29.
6. Diegelmann RF, Evans MC: Wound healing: an overview of acute, fibrotic
and delayed healing. Front Biosci 2004, 9:283-289.
7. Thannickal VJ, Toews GB, White ES, Lynch JP, Martinez FJ: Mechanisms of
pulmonary fibrosis. Annu Rev Med 2004, 55:395-417.
8. Postma DS, Timens W: Remodeling in asthma and chronic obstructive
pulmonary disease. Proc Am Thorac Soc 2006, 3:434-439.
9. Porter KE, Turner NA: Cardiac fibroblasts: At the heart of myocardial
remodeling. Pharmacology & Therapeutics 2009, 123:255-278.
10. Lindsey ML, Borg TK: Understanding the role of the extracellular matrix in
cardiovascular development and disease: where do we go from here?
Journal of Molecular and Cellular Cardiology 2010, 48:431-432.
11. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 2006,
6:392-401.
12. Nutrient Intakes from Food: Mean Amounts Consumed per Individual,
by Gender and Age, What We Eat in America, NHANES 2007-2008. U.S.
Department of Agriculture, Agricultural Research Service; 2010.
13. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST: Differential effects
of prostaglandin derived from omega-6 and omega-3 polyunsaturated
fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci
USA 2003, 100:1751-1756.
14. Cardoso CRB, Souza MA, Ferro EAV, Favoreto S, Pena JDO: Influence of
topical administration of n-3 and n-6 essential and n-9 nonessential
fatty acids on the healing of cutaneous wounds. Wound Repair and
Regeneration 2004, 12:235-243.
15. Menendez JA, Lupu R: Mediterranean dietary traditions for the molecular
treatment of human cancer: Anti-oncogenic actions of the main olive
oil’s monounsaturated fatty acid oleic acid (18: 1n-9). Current
Pharmaceutical Biotechnology 2006, 7:495-502.
16. Granados S, Quiles JL, Gil A, Ramirez-Tortosa AC: Dietary lipids and cancer.
Nutricion Hospitalaria 2006, 21:42-52.
17. Hovsepyan M, Sargsyan E, Bergsten P: Palmitate-induced changes in
protein expression of insulin secreting INS-1E cells. Journal of Proteomics
2010, 73:1148-1155.
18. Dutt MJ, Lee KH: Proteomic analysis. Curr Opin Biotechnol 2000, 11:176-179.
19. Pegorier JP, Le May C, Girard J: Control of gene expression by fatty acids.
J Nutr 2004, 134:2444S-2449S.
20. Khodadadi I, Griffin B, Thumser A: Differential effects of long-chain fatty
acids and clofibrate on gene expression profiles in cardiomyocytes. Arch
Iran Med 2008, 11:42-49.
21. Lee MH, Hong I, Kim M, Lee BH, Kim JH, Kang KS, Kim HL, Yoon BI,
Chung H, Kong G, Lee MO: Gene expression profiles of murine fatty liver
induced by the administration of valproic acid. Toxicol Appl Pharmacol
2007, 220:45-59.
22. Xiao JZ, Gregersen S, Pedersen SB, Kruhoffer M, Orntoft TF, Hermansen K:
The effect of chronic exposure to fatty acids on gene expression profile
in clonal insulin-producing cells. Diabetologia 2001, 44:A30-A30.
23. Joseph SJ, Robbins KR, Pavan E, Pratt SL, Duckett SK, Rekaya R: Effect of
diet supplementation on the expression of bovine genes associated
with Fatty Acid synthesis and metabolism. Bioinform Biol Insights 2010,
4:19-31.
24. Coyne GS, Kenny DA, Waters SM: Effect of dietary n-3 polyunsaturated
fatty acid supplementation on bovine uterine endometrial and hepatic
gene expression of the insulin-like growth factor system. Theriogenology
2011, 75:500-512.
25. Martins de Lima-Salgado T, Coccuzzo Sampaio S, Cury-Boaventura MF,
Curi R: Modulatory effect of fatty acids on fungicidal activity, respiratory
burst and TNF-alpha and IL-6 production in J774 murine macrophages.
Br J Nutr 2011, 105:1173-1179.
26. Hatanaka E, Levada-Pires AC, Pithon-Curi TC, Curi R: Systematic study on
ROS production induced by oleic, linoleic, and gamma-linolenic acids in
human and rat neutrophils. Free Radic Biol Med 2006, 41:1124-1132.
27. Siefken W, Hoppner H, Harris IR: Regulation of cholesterol synthesis by
oleic and palmitic acid in keratinocytes. Exp Dermatol 2000, 9:138-145.
28. Zhou L, Vessby B, Nilsson A: Quantitative role of plasma free fatty acids in
the supply of arachidonic acid to extrahepatic tissues in rats. J Nutr 2002,
132:2626-2631.
29. de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME: Plasma
total and free fatty acids composition in human non-alcoholic
steatohepatitis. Clin Nutr 2002, 21:219-223.
30. Tachibana H, Lee JH, Morinaga Y, Fujimura Y, Yamada K: Modulation of
proliferation and differentiation of C2C12 skeletal muscle cells by fatty
acids. Life Sciences 2009, 84:415-420.
31. Yonezawa T, Haga S, Kobayashi Y, Katoh K, Obara Y: Unsaturated fatty
acids promote proliferation via ERK1/2 and Akt pathway in bovine
mammary epithelial cells. Biochemical and Biophysical Research
Communications 2008, 367:729-735.
32. Pancholi V: Multifunctional alpha-enolase: its role in diseases. Cell Mol Life
Sci 2001, 58:902-920.
33. Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL: The cell biology of
the plasminogen system. FASEB J 1995, 9:939-945.
34. Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M,
Levens D: A sequence-specific, single-strand binding protein activates
the far upstream element of c-myc and defines a new DNA-binding
motif. Genes Dev 1994, 8:465-480.
Magdalon et al. Lipids in Health and Disease 2011, 10:218
http://www.lipidworld.com/content/10/1/218
Page 7 of 835. He L, Liu J, Collins I, Sanford S, O’Connell B, Benham CJ, Levens D: Loss of
FBP function arrests cellular proliferation and extinguishes c-myc
expression. Embo Journal 2000, 19:1034-1044.
36. Liu J, He L, Collins I, Ge H, Libutti D, Li J, Egly JM, Levens D: The FBP
interacting repressor targets TFIIH to inhibit activated transcription. Mol
Cell 2000, 5:331-341.
37. Michelotti GA, Michelotti EF, Pullner A, Duncan RC, Eick D, Levens D:
Multiple single-stranded cis elements are associated with activated
chromatin of the human c-myc gene in vivo. Mol Cell Biol 1996,
16:2656-2669.
38. Levens D: Disentangling the MYC web. Proc Natl Acad Sci USA 2002,
99:5757-5759.
39. Levens DL: Reconstructing MYC. Genes Dev 2003, 17:1071-1077.
40. Johnson JD, Bernal-Mizrachi E, Alejandro EU, Han Z, Kalynyak TB, Li H,
Beith JL, Gross J, Warnock GL, Townsend RR, et al: Insulin protects islets
from apoptosis via Pdx1 and specific changes in the human islet
proteome. Proc Natl Acad Sci USA 2006, 103:19575-19580.
41. Keane DC, Takahashi HK, Dhayal S, Morgan NG, Curi R, Newsholme P:
Arachidonic acid actions on functional integrity and attenuation of the
negative effects of palmitic acid in a clonal pancreatic beta-cell line. Clin
Sci (Lond) 2011, 120:195-206.
42. Ramagli LS, Rodriguez LV: Quantitation of Microgram Amounts of Protein
in Two-Dimensional Polyacrylamide-Gel Electrophoresis Sample Buffer.
Electrophoresis 1985, 6:559-563.
doi:10.1186/1476-511X-10-218
Cite this article as: Magdalon et al.: A proteomic analysis of the
functional effects of fatty acids in NIH 3T3 fibroblasts. Lipids in Health
and Disease 2011 10:218.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Magdalon et al. Lipids in Health and Disease 2011, 10:218
http://www.lipidworld.com/content/10/1/218
Page 8 of 8